Ozaki术后亚临床瓣叶血栓两例报告
该文报告两例Ozaki术后12和23个月随访发现的亚临床瓣叶血栓(SLT),抗凝治疗后超声心动图显示血流动力学和瓣叶活动改善。作者称这是成人Ozaki术后首例SLT报告,建议术后前3个月抗凝并于6个月时复查,同时呼吁研究替代戊二醛的处理方法。
要点
- Ozaki术后随访12和23个月各发现一例亚临床瓣叶血栓。
- 抗凝治疗后超声心动图显示血流动力学与瓣叶活动改善。
- 建议术后前3个月抗凝,6个月时进行控制。
核心结论
- Ozaki术后可发生亚临床瓣叶血栓,抗凝治疗可改善血流动力学和瓣叶活动。
- 戊二醛细胞毒性与部分内皮化可能促进血栓形成,并为后期心内膜炎和瓣膜退变创造条件。
研究设计与样本
- 病例报告,报告两例Ozaki术后亚临床瓣叶血栓。
主要发现
- 两例亚临床瓣叶血栓分别于随访12个月和23个月时发现。
- 启动抗凝治疗后,后续超声心动图显示血流动力学和瓣叶活动改善。
- 作者称这是成人Ozaki术后首例亚临床瓣叶血栓报告。
关键数值与推荐
- 建议术后前3个月进行抗凝,并在6个月时进行控制。
临床怎么用
- Ozaki术后应关注亚临床瓣叶血栓,可考虑术后前3个月抗凝并于6个月复查。
- 对术后瓣叶活动异常者应警惕亚临床瓣叶血栓并及时评估。
局限性
- 仅两例病例报告,证据级别有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Aortic valve reconstruction with autologous glutaraldehyde-fixed pericardium (Ozaki procedure) represents an alternative to conventional prosthetic valve replacement, allowing excellent haemodynamic outcomes. We report two cases of subclinical leaflet thrombosis (SLT) at 12 and 23 months of follow-up. Anticoagulation was initiated, and later echocardiography showed haemodynamic and mobility improvement. SLT is well documented for bioprosthetic valve. To our knowledge, this is the first report for Ozaki procedure in an adult population. Glutaraldehyde is known for cytotoxicity, and partial endothelialization can be responsible for thrombosis, creating favourable conditions for later endocarditis and degeneration. Anticoagulation should be recommended postoperatively for the first 3 months with control at 6 months. Finally, alternative treatment to glutaraldehyde should be investigated.
引用
- van Steenberghe M, Perret F, Myers PO, et al. Subclinical leaflet thrombosis in Ozaki procedure. Interdiscip Cardiovasc Thorac Surg. 2025. PMID: 40036979. doi:10.1093/icvts/ivaf051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。